Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genomic Updates To Drug Labeling Could Result From Medco/FDA Partnership

Executive Summary

FDA could use results from a new research collaboration with Medco to update existing drug labeling with genomic information. Announced by Medco on Aug. 18, the project calls for the pharmacy benefit management company to draw from its pharmacy claims data base and its own physician and member surveys to produce a series of reports on the impact of genetic testing on drug efficacy and safety

You may also be interested in...



Warfarin Sensitivity Testing: Medco/Mayo Study Results Due Early 2010

Medco is planning to release an observational study in early 2010 on the benefits of pharmacogenomic testing in warfarin dosing. It hopes the results will increase payer acceptance of the approach to treatment

Warfarin Sensitivity Testing: Medco/Mayo Study Results Due Early 2010

Medco is planning to release an observational study in early 2010 on the benefits of pharmacogenomic testing in warfarin dosing. It hopes the results will increase payer acceptance of the approach to treatment

Medco Personalized Medicine Research Shows “Real World” Promise – Frueh

Medco's research can advance the cause of personalized medicine by proving its benefits in a "real world" setting, according to Felix Frueh, the firm's new VP of research and development for personalized medicine

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel